Phase 1 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to understand what the trial involves and any possible side effects, and you are willing to take part voluntarily.
- Your bone marrow and other major organs (such as heart, kidneys, and lungs) are working well enough to meet the trial's requirements.
- Your liver is functioning at an adequate level based on blood tests.
- You have been diagnosed with a solid tumor that is hormone receptor (HR)-positive or HER2-negative.
Who may not be able to join:
- You are planning to receive any other cancer treatment while taking part in this trial.
- You currently have active cancer that has spread to the brain.
- You have a poorly controlled or serious heart condition, including heart failure.
- You have previously been treated with a drug called fulvestrant.
- You have a clinically significant uterine lining (endometrial) condition, such as abnormal thickening of the uterine lining or irregular uterine bleeding.
- You have an uncontrolled long-term (chronic) health condition seriously affecting the lungs, liver, kidneys, or heart.
- You currently have active tuberculosis (TB) that requires medication.
- You are pregnant, breastfeeding, or planning to become pregnant during the study.
- You have a known history of serious liver disease, or you have untreated active hepatitis B (confirm with trial site for full details on how this is tested).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +61 02 9299 0433
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Safety by reporting incidence and severity of Adverse events (graded as per CTCAE V5.0) of adverse events (AEs) and serious adverse events (SAEs),
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.